首页> 外文期刊>BMC Complementary and Alternative Medicine >Consumers of natural health products: natural-born pharmacovigilantes?
【24h】

Consumers of natural health products: natural-born pharmacovigilantes?

机译:天然保健品的消费者:天然药物吗?

获取原文
           

摘要

Background Natural health products (NHPs), such as herbal medicines and vitamins, are widely available over-the-counter and are often purchased by consumers without advice from a healthcare provider. This study examined how consumers respond when they believe they have experienced NHP-related adverse drug reactions (ADRs) in order to determine how to improve current safety monitoring strategies. Methods Qualitative semi-structured interviews were conducted with twelve consumers who had experienced a self-identified NHP-related ADR. Key emergent themes were identified and coded using content analysis techniques. Results Consumers were generally not comfortable enough with their conventional health care providers to discuss their NHP-related ADRs. Consumers reported being more comfortable discussing NHP-related ADRs with personnel from health food stores, friends or family with whom they had developed trusted relationships. No one reported their suspected ADR to Health Canada and most did not know this was possible. Conclusion Consumers generally did not report their suspected NHP-related ADRs to healthcare providers or to Health Canada. Passive reporting systems for collecting information on NHP-related ADRs cannot be effective if consumers who experience NHP-related ADRs do not report their experiences. Healthcare providers, health food store personnel, manufacturers and other stakeholders also need to take responsibility for reporting ADRs in order to improve current pharmacovigilance of NHPs.
机译:背景技术天然保健产品(NHP),例如草药和维生素,可以在非处方药中广泛获得,并且通常由消费者购买而没有医疗保健提供者的建议。这项研究调查了消费者在认为自己经历了NHP相关的药品不良反应(ADR)时如何应对,以确定如何改善当前的安全监控策略。方法对经历过自我识别的NHP相关ADR的12位消费者进行了定性半结构化访谈。使用内容分析技术识别并编码了关键的紧急主题。结果消费者通常对传统医疗保健提供者不满意,无法讨论其与NHP相关的ADR。消费者报告说,与与健康食品商店,朋友或家人建立了可信赖关系的人员讨论与NHP相关的ADR时,他们更自在。没有人向加拿大卫生部报告可疑的ADR,而且大多数人不知道这是可能的。结论消费者通常不会向医疗保健提供者或加拿大卫生部报告其与NHP有关的可疑ADR。如果经历了与NHP相关的ADR的消费者未报告其经历,则用于收集与NHP相关的ADR信息的被动报告系统将无法有效发挥作用。医疗保健提供者,保健食品商店人员,制造商和其他利益相关者还需要承担报告ADR的责任,以改善NHP的当前药物警戒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号